Drug giant Novartis AG has initiated a strategic review of its India-listed subsidiary Novartis India Ltd, amid reports that it is considering selling its 71% stake in the Indian business. A Novartis India spokesperson confirmed that Novartis AG has commenced this strategic review to assess its shareholding in the listed...